Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma

NCT01356680 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT01356680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma
Lead sponsor
University of Cologne
Phase
Phase 3
Overall status
Completed
Start date
January 13, 2012
Completion date
March 23, 2020
Enrollment
1,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma